UAN on NYSE
CVR PARTNERS, LP
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with AMERICAN VANGUARD CORP, Bioceres Crop Solutions Corp. or The Scotts Miracle-Gro Company, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Product, UAN brought in 62% of the revenue CVR PARTNERS, LP broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Product, UAN | $431.5M | $312.0M | $374.3M |
| Product, Ammonia | $161.0M | $130.0M | $143.1M |
| Products, Other | $60.3M | $52.9M | $51.2M |
| Product, Urea Products | $28.7M | $30.4M | $37.4M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue73¢$442.7M
- Selling, general and admin6¢$33.6M
- Other costs5¢$31.1M
- Income tax0¢$23.0K
- Profit16¢$98.7M
Out of $606.0M in revenue.3
Where each dollar of operating cash went, fiscal 2025
- Kept or used elsewhere100¢$149.6M
Out of $149.6M of cash from operations.3
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net sales | $606.0M | $525.3M | $681.5M |
| Cost of materials and other | $106.7M | $104.1M | $134.4M |
| Direct operating expenses (exclusive of depreciation and amortization) | $254.1M | $214.2M | $234.9M |
| Depreciation and amortization | $81.9M | $88.1M | $79.7M |
| Cost of sales | $442.7M | $406.5M | $449.0M |
| Selling, general and administrative expenses | $33.6M | $28.4M | $29.5M |
| Loss on asset disposals | $1.1M | $100.0K | $1.5M |
| Operating income | $128.7M | $90.4M | $201.4M |
| Interest expense, net | -$30.3M | -$29.8M | -$28.7M |
| Other income (expense), net | $326.0K | $453.0K | -$33.0K |
| Income before income taxes | $98.6M | $61.0M | $172.7M |
| Income tax (benefit) expense | -$23.0K | $77.0K | $289.0K |
| Net income | $98.7M | $60.9M | $172.4M |
| Basic earnings per common unit (in dollars per unit) | $9.33 | $5.76 | $16.31 |
| Diluted earnings per common unit (in dollars per unit) | $9.33 | $5.76 | $16.31 |
| Basic (in units) | 10.6M shares | 10.6M shares | 10.6M shares |
| Diluted (in units) | 10.6M shares | 10.6M shares | 10.6M shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Cash and cash equivalents | $69.2M | $90.9M |
| Accounts receivable, net | $59.0M | $65.2M |
| Inventories | $82.7M | $75.6M |
| Prepaid expenses | $1.5M | $1.3M |
| Other current assets | $1.5M | $632.0K |
| Total current assets | $213.9M | $233.5M |
| Property, plant and equipment, net | $711.8M | $735.6M |
| Other long-term assets | $43.8M | $49.6M |
| Total assets | $969.5M | $1.0B |
| Deferred revenue | $23.0M | $50.8M |
| Other current liabilities | $25.4M | $24.0M |
| Total current liabilities | $96.8M | $111.3M |
| Long-term debt and finance lease obligations, net of current portion | $569.1M | $568.0M |
| Long-term deferred revenue | $20.6M | $27.0M |
| Other long-term liabilities | $17.3M | $19.4M |
| Total long-term liabilities | $606.9M | $614.3M |
| Common unitholders, 10,569,637 and 10,569,637 units issued and outstanding as of December 31, 2025 and 2024, respectively | $265.7M | $293.1M |
| General partner interest | $1.0K | $1.0K |
| Total partners capital | $265.7M | $293.1M |
| Total liabilities and partners capital | $969.5M | $1.0B |
| Common units issued (in units) | 10.6M shares | 10.6M shares |
| Common units outstanding (in units) | 10.6M shares | 10.6M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $98.7M | $60.9M | $172.4M |
| Depreciation and amortization | $81.9M | $88.1M | $79.7M |
| Amortization of deferred financing costs and original issue discount | $730.0K | $696.0K | $754.0K |
| Loss on asset disposals | $1.1M | $100.0K | $1.5M |
| Share-based compensation | $9.8M | $4.9M | $8.2M |
| Other adjustments | -$65.0K | $76.0K | $222.0K |
| Accounts receivable | $6.3M | -$23.3M | $27.5M |
| Inventories | -$7.8M | -$5.7M | $6.7M |
| Prepaid expenses and other current assets | -$673.0K | $1.7M | $1.4M |
| Accounts payable | $5.7M | -$5.6M | -$23.8M |
| Deferred revenue | -$34.2M | $28.6M | -$23.5M |
| Other current liabilities | -$11.8M | $13.0K | -$7.7M |
| Net cash provided by operating activities | $149.6M | $150.5M | $243.5M |
| Capital expenditures | -$50.8M | -$37.1M | -$24.2M |
| Proceeds from the sale of assets | $54.0K | $4.0K | $0 |
| Return of equity method investment | $6.7M | $5.2M | $21.5M |
| Net cash used in investing activities | -$44.1M | -$31.9M | -$2.7M |
| Cash distributions to common unitholders | -$126.0M | -$70.7M | -$281.4M |
| Other financing activities | -$1.2M | -$2.4M | -$500.0K |
| Net cash used in financing activities | -$127.2M | -$73.1M | -$281.9M |
| Net (decrease) increase in cash and cash equivalents | -$21.6M | $45.6M | -$41.1M |
Recent filings
- Jul 29, 20268-K
- Jul 29, 202610-Q
- Jun 26, 20263
- Jun 23, 20268-K
- Apr 29, 20268-K
- Apr 29, 202610-Q
- Mar 26, 20263
- Mar 18, 20268-K
- Mar 3, 20268-K
- Feb 18, 20268-K
- Feb 18, 202610-K
- Jan 26, 20268-K
- Jan 23, 20263
- Jan 22, 20268-K
- Jan 5, 20268-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10